Diagnostic testing kit producer Immunodiagnostic Systems Holdings has allotted 66,723 ordinary shares to satisfy an exercise of options.
The board also allotted 2,495 shares allotted to satisfy options exercised under a SAYE scheme.
In aggregate 69,218 ordinary shares have been allotted and application will be made at the earliest practicable opportunity for admission of the new ordinary shares to trading on AIM.
Story provided by Business Financial Newswire
